WO2016003203A1 - Medical band - Google Patents
Medical band Download PDFInfo
- Publication number
- WO2016003203A1 WO2016003203A1 PCT/KR2015/006785 KR2015006785W WO2016003203A1 WO 2016003203 A1 WO2016003203 A1 WO 2016003203A1 KR 2015006785 W KR2015006785 W KR 2015006785W WO 2016003203 A1 WO2016003203 A1 WO 2016003203A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- band
- medical
- magnet
- wound
- dressing
- Prior art date
Links
- 208000027418 Wounds and injury Diseases 0.000 claims description 56
- 206010052428 Wound Diseases 0.000 claims description 55
- 230000029663 wound healing Effects 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 14
- QMGYPNKICQJHLN-UHFFFAOYSA-M Carboxymethylcellulose cellulose carboxymethyl ether Chemical compound [Na+].CC([O-])=O.OCC(O)C(O)C(O)C(O)C=O QMGYPNKICQJHLN-UHFFFAOYSA-M 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000416 hydrocolloid Substances 0.000 claims description 9
- 239000003102 growth factor Substances 0.000 claims description 8
- 239000005556 hormone Substances 0.000 claims description 7
- 229940088597 hormone Drugs 0.000 claims description 7
- 229920005830 Polyurethane Foam Polymers 0.000 claims description 6
- 229920006264 polyurethane film Polymers 0.000 claims description 6
- 239000011496 polyurethane foam Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 5
- 239000008273 gelatin Substances 0.000 claims description 5
- 229920000159 gelatin Polymers 0.000 claims description 5
- 235000019322 gelatine Nutrition 0.000 claims description 5
- 235000011852 gelatine desserts Nutrition 0.000 claims description 5
- 239000000017 hydrogel Substances 0.000 claims description 5
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 229920002367 Polyisobutene Polymers 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 229940035676 analgesics Drugs 0.000 claims description 3
- 239000000730 antalgic agent Substances 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 238000007711 solidification Methods 0.000 claims description 3
- 230000008023 solidification Effects 0.000 claims description 3
- 150000003431 steroids Chemical class 0.000 claims description 3
- 230000017423 tissue regeneration Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 16
- 230000036558 skin tension Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 10
- 210000004204 blood vessel Anatomy 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000035876 healing Effects 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 230000024883 vasodilation Effects 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- 102100031168 CCN family member 2 Human genes 0.000 description 2
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 2
- 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
- 108090000381 Fibroblast growth factor 4 Proteins 0.000 description 2
- 102100028072 Fibroblast growth factor 4 Human genes 0.000 description 2
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 2
- 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 2
- 101000777550 Homo sapiens CCN family member 2 Proteins 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
- 101000844802 Lacticaseibacillus rhamnosus Teichoic acid D-alanyltransferase Proteins 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 102000006747 Transforming Growth Factor alpha Human genes 0.000 description 2
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 2
- 102000011117 Transforming Growth Factor beta2 Human genes 0.000 description 2
- 101800004564 Transforming growth factor alpha Proteins 0.000 description 2
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 2
- 101800000304 Transforming growth factor beta-2 Proteins 0.000 description 2
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 description 2
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000013013 elastic material Substances 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000002820 sympathetic nervous system Anatomy 0.000 description 2
- 238000009941 weaving Methods 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 108090001047 Fibroblast growth factor 10 Proteins 0.000 description 1
- 102100028412 Fibroblast growth factor 10 Human genes 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- -1 PDGF Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000003373 anti-fouling effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0226—Adhesive bandages or dressings with fluid retention members characterised by the support layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
Definitions
- the present invention relates to medical bands and to band-type medical supplies useful for the treatment of wounds and the like.
- a wound is a breakdown of normal anatomy of the body. When a wound occurs, the wound healing system and the immune system work simultaneously in the body to heal the wound.
- the goal of medicine is to restore it to its normal anatomical appearance and function.
- Thoracic tissue plays a very important role in preventing wounds from sticking together and spreading, and prevents germs and foreign substances from penetrating into the body through the wound, whereas hypertrophic scar ) Or keloids are generated, and the appearance of the vertebrae causes psychological inferiority, and is inappropriate for human function.
- adverse effects may also occur in the bonding or healing of the bones.
- the present invention provides a medical band that can be prevented as much as possible to open the wound caused by the tension of the skin of the wound.
- the present invention also provides a medical band capable of actively inducing the human wound healing system.
- the present invention provides a medical band that can maintain a wet state by using and maintaining the self-exudation as it is.
- Medical band according to the present invention is applied to at least a portion of the human body, and includes a band member having a biased elasticity.
- It may also include; a pair of bar-shaped magnet member arranged to form a magnetic field in the opposite direction to the band member.
- the pair of magnet members may be provided in parallel with a predetermined interval spaced apart.
- the magnet member may be provided at any one of an attachment surface for attaching the band member to a human body, another side surface of the attachment surface of the band member, and an inside of the band member.
- the band member may have different elasticity in the longitudinal direction of the magnet member and elasticity in the arrangement direction of the pair of magnet members.
- the band member may be formed to have elasticity in the arrangement direction of the pair of magnet members and not elastic in the longitudinal direction of the magnet member.
- the band member between the pair of magnet members may be formed of an inelastic portion having no elasticity in the arrangement direction of the pair of magnet members.
- one surface of the band member may be provided with a dressing member applied to the wound of the human body between the pair of magnet members.
- a dressing member applied to a wound of a human body may be integrally provided between at least a portion of the band member including the center portion and the magnet member.
- the cover member is attached to one surface of the band member, the portion corresponding to the region other than the dressing member may be further included a woven member having a biased elasticity.
- the dressing member may include at least one or more of antibiotics, ointments, anti-inflammatory agents, analgesics, wound healing growth factors, hormones, steroids, autologous cells and synthetic tissue regeneration promoters.
- the dressing member may be formed of a wet dressing material.
- the dressing member may include a layer formed of at least one of a hydrocolloid, a polyurethane foam, a polyurethane film, and a hydrogel.
- the dressing member may include a hydrocolloid layer formed of any one of carboxymethyl cellulose (CMC) powder or a mixture containing the CMC powder.
- CMC carboxymethyl cellulose
- the CMC powder mixture may be formed by mixing and solidifying CMC powder and powder of at least one of gelatin, gelatin, pectin, alginate, and resin.
- the CMC powder mixture may be adhered by polyisobutylene during solidification.
- the magnet member may be provided as any one type of permanent magnet and electromagnet.
- an additional holding force acting in the direction of suturing the wound is provided so that the wound may be in accordance with the tension of the skin. Minimize what's going to happen.
- FIG. 1 is a perspective view showing a state of one side of a medical band according to an embodiment of the present invention.
- Figure 2 is a perspective view showing the other side of the medical band according to an embodiment of the present invention.
- FIG 3 is a perspective view showing a state of the medical band according to another embodiment.
- Figure 4 is a perspective view showing the state of the medical band according to another embodiment.
- FIG 5 is a perspective view showing a state of the medical band according to the embodiment in which the type of the magnet is modified.
- FIG. 6 is a side view showing a state of the medical band of FIG.
- FIG. 7 is a schematic view illustrating an example of applying the medical band of FIG. 4 to an affected part.
- FIG. 8 is a perspective view showing a medical band according to another embodiment.
- 9 to 11 are each a perspective view showing a medical band according to yet another embodiment.
- FIG. 12 is a perspective view illustrating a medical band using an electromagnet to which DC power is applied according to another embodiment.
- FIG. 13 is a perspective view illustrating a medical band using an electromagnet to which an AC power source is applied according to still another embodiment.
- Medical band according to the present invention is applied to at least a portion of the human body, and includes a band member having a biased elasticity.
- FIGS. 1 to 3 A medical band according to an embodiment of the present invention will be described with reference to FIGS. 1 to 3.
- 1 is a perspective view showing the appearance of the mounting surface of the medical band according to an embodiment of the present invention
- Figure 2 is a perspective view showing the other side of the medical band according to an embodiment of the present invention
- Figure 3 is another embodiment Is a perspective view showing the state of the medical band according to.
- the band member 100 and the magnet members 210a and 210b according to the exemplary embodiment of the present invention are provided.
- the band member 100 is a member attached to a part of the human body to perform a function of protecting a wound, dressing, and the like, and the magnet members 210a and 210b are formed on one surface of the band member 100 as shown in FIG. 1. It is provided to perform the function of helping the healing of the human wound.
- the other side of the band member 100 is not provided with a separate configuration as shown in FIG. 2, and the other side has the durability or anti-contamination function of the band member 100 itself. Can be formed into a layer or film.
- the magnet members 210a and 210b are arranged in parallel with each other on one side of the band member 100 while being spaced apart from each other. At this time, the magnet members 210a and 210b are preferably provided such that the polarities of the magnet members 210a and 210b are opposite to each other to form a reverse magnetic field. Due to the arrangement of the magnet members 210a and 210b, an attraction force acts between the two magnet members 210a and 210b.
- the magnet members 210a and 210b may be implemented as any type of magnet such as a permanent magnet and an electromagnet.
- a permanent magnet for example, it is possible to simply be provided only by a permanent magnet without any additional member, it is also possible to implement using an electromagnet having a power input terminal. That is, there is no limitation on the kind of magnet included in the medical band according to the present invention.
- One of the functions of the magnet members 210a and 210b according to the present embodiment is to draw red blood cells present in normal blood vessels, thereby increasing oxygen partial pressure in the blood around the wound, which contains hemoglobin in the red blood cells, and the hemoglobin is Fe ++ /. Fe +++ exists.
- the magnet members 210a and 210b form a magnetic field to guide red blood cells around the wound, thereby causing congestion of large and thick blood vessels themselves. This results in larger openings in the vessel wall, allowing T, B, K lymphocytes and leukocytes, monocytes, macrophages, and platelets, which are involved in normal wound healing and immune system, to move into and promote tissue.
- EGF EGF
- FGF IGF
- AGF AGF
- PDGF PDGF
- BMP TGF- ⁇ 1, TGF- ⁇ 2, TGF- ⁇ 3, TGF- ⁇ , TNF- ⁇ , PDGF, FGF-1, FGF-2, FGF-4, FGF-7 (KGF-1), FGF-10 (KGF-2), EGF.
- Many wound healing hormones and growth factors such as IGF-1 / Sm-C, IL-1 ⁇ , IL-1 ⁇ , CTGF, and VEGF, can be secreted to further shorten the healing period of wounds.
- the magnetic field promotes the movement of blood, body fluids and tissue fluids. That is, their continuous production and stimulation are simultaneously performed, and research data on them are widely known, and the magnetic field is used for regeneration of skin and soft tissues, promoting wound healing, union and remodeling of fractured bones. There are numerous reports to promote.
- the medical band 10 is also available in both models of skin and soft tissue wound models and fracture treatment models.
- the band member 100 is formed in a plate shape as a whole, and magnet members 210a and 210b are attached to one surface thereof.
- the magnet members 210a and 210b are attached to be spaced apart from each other by a predetermined interval so that a portion PH1 of one surface of the band member 100 is exposed to the outside between the magnet members 210a and 210b. Some of these areas PH1 may be physically protected, such as contact with the wound or at a position corresponding to the wound so that the wound is isolated from the outside.
- the band member 100 according to the present invention is formed to have a deflection elasticity.
- the band member 100 is formed so as not to have elasticity in the length direction (D2-D2 ⁇ ) of the magnet members (210a, 210b), while in the arrangement direction (D1-D1 ⁇ ) of the magnet members (210a, 210b). Is preferably formed to have elasticity. This reduces the tension on the window and minimizes dead space. This will be described later in detail.
- the region PH1 corresponding to the wound in the band member 100 may be formed inelastically to facilitate fixing of the dressing member or the like.
- the band member 100 may be formed in a gauze type or a wet dressing type. In the case of a gauze type, it is easy to attach a magnet or the like, and it is also advantageous to form a biased elasticity through weaving. When formed in a wet dressing type, a more advantageous effect can be obtained in terms of healing of wounds.
- the band member 100 may include a layer formed of at least one material of hydrocolloid, polyurethane foam, polyurethane film, and hydrogel.
- the inelastic members 140a and 140b as shown in FIG. 3. It is possible to arrange the at predetermined intervals.
- the first inelastic members 140a may be arranged at regular intervals in the longitudinal direction, and the second inelastic members 140b may be arranged to connect some of the first inelastic members 140a.
- the portion in which only the first non-elastic member 140a is arranged has no elasticity in the longitudinal direction D2-D2 ⁇ but has elasticity in the width direction D1-D1 ⁇ .
- the portion of the first non-elastic member 140a and the second non-elastic member 140b is in a state in which elasticity is minimized in any direction.
- the portion in which only the first inelastic member 140a is arranged serves to reduce the tension of the wound, and the portion in which the first inelastic member 140a and the second inelastic member 140b overlap with each other is attached with a dressing agent. To facilitate the function.
- the inelastic members 140a and 140b may be provided in a manner of being attached to the surface of the band member 100 or provided in a manner of being provided inside the band member 100.
- FIGS. 4 to 7 A medical band according to another embodiment will be described with reference to FIGS. 4 to 7.
- Figure 4 is a perspective view showing the state of the medical band according to another embodiment
- Figure 5 is a perspective view showing the state of the medical band according to an embodiment in which the type of the magnet is modified.
- Figure 6 is a side view showing the state of the medical band of Figure 4
- Figure 7 is a schematic diagram showing an exemplary appearance of applying the medical band of Figure 4 to the affected part.
- the medical band 10b according to the present embodiment has a difference in that it further includes a separate dressing member 250 between the magnet members 210a and 210b.
- the band member 100 according to the present embodiment preferably has no elasticity in the region to which the dressing member 250 is attached.
- Dressing member 250 may be provided in a manner such as gauze or wet dressing material.
- the dressing member may include at least one or more of antibiotics, ointments, anti-inflammatory agents, analgesics, wound healing growth factors, hormones, steroids, autologous cells, and synthetic tissue regeneration accelerators to assist or enhance the healing of wounds. .
- the dressing member 250 may include a layer formed of any one type of hydrocolloid, polyurethane foam, polyurethane film, and hydrogel, and these layers may be multilayered as shown in FIG. 6 according to the purpose. It is also possible to comprise (251, 253, 255).
- the hydrocolloid layer may be formed of any one of carboxymethyl cellulose (CMC) powder or a mixture containing the CMC powder, and the CMC powder mixture may be CMC powder, gelatin, pectin, alginate It may be formed by mixing and solidifying the powder of at least one of the resin and (gum). At this time, the CMC powder mixture may be bonded by polyisobutylene during solidification.
- CMC powder mixture may be bonded by polyisobutylene during solidification.
- PVA polyvinyl alcohol
- PVAc polyvinyl acetate
- the dressing member 250 may be formed together with the polyurethane film 251, the polyurethane foam 253, and the hydrocolloid layer 255.
- the hydrocolloid layer 255 is gelated by quickly absorbing the exudates.
- the polyurethane foam 253 is hydrophilic and absorbs the exudates and together with the polyurethane film 251 creates a wound healing environment.
- the polarities of the magnet members 210a and 210b may be arranged in various forms as long as the magnetic field formed therein maintains the reverse direction.
- a magnet of a type having a different polarity between the upper and lower surfaces instead of the magnet having a different polarity in the longitudinal direction.
- the attraction force acts between the two magnet members 210a and 210b, but before that, the two magnet members 210a and 210b have a greater rotational force to face each other with different polarities.
- the rotational force of the two magnet members 210a and 210b acts together with the attraction force between the two magnet members by pressing the human body around the wound relatively deeply compared to the embodiments described above. It can further increase the action and effect of reducing the tension acting.
- the band member 100 may be formed to be divided into an elastic region PH1b and an inelastic region PH1a.
- the dressing member 250 is fixed to the inelastic region PH1a to protect the wound, and the elastic region PH1b is attached to the human body so that the entire medical band 10b including the magnet members 210a and 210b is attached to the human body. Function to fix.
- the inelastic region PH1b does not attach to the human body and has no elasticity, and thus does not affect the tension applied to the human body or acting on the human body.
- the outer side is attached to the human body and has elasticity, thereby pulling the human body toward the center.
- the dead space between the two sections should be minimized while minimizing the tension between the two sections of the wound.
- blood supply should be activated so that sufficient oxygen and nutrients can be supplied smoothly.
- hormones and growth factors directly involved in wound healing specifically, EGF, FGF, IGF, and AGF.
- PDGF, BMP TGF- ⁇ 1, TGF- ⁇ 2, TGF- ⁇ 3, TGF- ⁇ , TNF- ⁇ , PDGF, FGF-1, FGF-2, FGF-4, FGF-7 (KGF-1), FGF- 10 (KGF-2), EGF. It is very important to ensure that IGF-1 / Sm-C, IL-1 ⁇ , IL-1 ⁇ , CTGF, VEGF, etc. are supplied sufficiently in the shortest period.
- the wound W has a cohesive force due to the elasticity of the band member 100 and the magnet members 210a and 210b.
- the attraction force according to the magnetic field of acts together to offset the tension to open the both ends of the wound (W).
- the tension of the human body is maintained as it is, and both end surfaces of the wound W are Unnecessary external forces other than the force necessary to prevent the opening does not work.
- the cohesion force due to the elasticity and the attraction force due to the magnetic field act only on the outside of the first point P1 and the second point P2, so that the wound W is not changed or applied directly, thereby effectively healing the wound. It is advantageous for environmental composition.
- the magnet members 210a ′ and 210b ′ may be provided on the upper side of the band member 100, that is, on the other side of the dressing member 250 provided on the attachment surface.
- the magnet members 210a ⁇ and 210b ⁇ may stimulate the human body by preventing the magnet members 210a ⁇ and 210b ⁇ from directly contacting the human body while maintaining the functions and effects of the magnet members 210a ⁇ and 210b ⁇ .
- the magnet members 210a 'and 210b' can be prevented from being corroded or contaminated due to the effluent from the wound.
- the adhesive surface of the band member 100 can be variously configured according to the size and type of the wound.
- FIGS. 9 through 11 are each a perspective view showing a medical band according to yet another embodiment.
- the medical band 10d is characterized in that the magnet members 210a and 210b are included in the band member 100d.
- the magnet members 210a and 210b may be provided inside during the weaving or manufacturing process of the band member 100d.
- the skin of the magnet members 210a and 210b does not come into direct contact with each other, not only the area PH1 between the magnet members 210a and 210b but also the entire surface of the band member 100d in contact with the human body for wound healing.
- an advantageous member, material and the like there is an advantage that the tension canceling effect of the wound by the magnet members 210a and 210b can be obtained in the same manner.
- the material of the band member 100d is not particularly limited. That is, it is possible to use various materials, such as a gauze type or a wet dressing material type. Therefore, in the present embodiment, it is possible to implement the band member 100d itself as a dressing member (wet dressing material) without having to attach a separate dressing member.
- the medical band 10e may be manufactured so that the band member 100 is divided into three parts in one piece but functional and material.
- the band member 100e according to the present exemplary embodiment is divided into three parts, the dressing part 151 at the center and the adhesive part 153 at both sides, based on the width direction.
- Dressing unit 151 may be formed of the same material as the dressing members of the above-described embodiments, and serves to directly contact the wound to create a wound healing environment.
- the adhesive parts 153 on both sides are attached to the human body in a state of enclosing the magnet members 210a and 210b or attached to the upper or lower ends. In this case, the adhesive parts 153 may be formed to have elasticity only in the width direction, as in the above-described embodiments.
- an outer skin member 150 may be further included on one surface of the band members 151 and 153 that is not attached to the human body.
- the outer shell member 150 may serve to facilitate the attachment of the band members 151 and 153, add an antifouling function, and increase durability.
- a function of helping rapid wound healing may be performed.
- FIG. 12 is a perspective view illustrating a medical band using an electromagnet to which DC power is applied according to still another embodiment
- FIG. 13 is a perspective view illustrating a medical band using an electromagnet to which AC power is applied according to another embodiment.
- FIG. 12 illustrates a case in which the magnet members 213a and 213b are implemented by electromagnets, and DC power is applied to operate the magnet members 213a and 213b.
- the current returns through the conductive line 215 via the first magnet member 213b and the second magnet member 213a sequentially.
- Each of the first magnet member 213b and the second magnet member 213a is formed by winding in the same direction using the conductive wire 215, and the first magnet member 213b is a current input from the DC power supply 500. And the second magnet member 213a is operated by a current returning to the DC power supply 500, so that the polarities of the first magnet member 213b and the second magnet member 213a are formed in opposite directions. . Therefore, like the permanent magnet described above, the attraction force acts between the first magnet member 213b and the second magnet member 213a.
- an AC power is applied to the first magnet member 213b and the second magnet member 213a so that the time-varying magnetic field is around the first magnet member 213b and the second magnet member 213a. It is also possible to allow this to be formed.
- various AC power sources such as sine wave or pulse type can be applied as AC power.
- sine wave or pulse type power When a sine wave or pulse type power is applied, an attractive force is periodically applied between the two magnet members 213a and 213b, thereby circulating the body fluid and / or blood around the wound.
- the time-varying magnetic field is induced to the magnet members 213a and 213b by the AC power supply 510, the time-varying magnetic field is formed around the wound, so that the blood in the D3-D3 ⁇ direction or the reverse direction is changed according to the dynamo effect.
- the circulation of is promoted. This not only contributes to the supply of new blood but also acts to ensure sufficient supply of hormones and growth factors directly involved in wound healing around the wound.
- the effect of the magnet member according to the above various embodiments can be summarized as follows.
- vasodilation occurs and thus the gap between the vascular cells is expanded, so that various inflammatory cells can be actively introduced into the wound site.
- the immune system is activated, and wound healing hormones and growth factors are supplied in a large amount in a short time, so that wound healing can be accelerated.
- erythrocytes containing hemoglobin containing Fe ++ / Fe +++ are aggregated into the magnetic field for both static and time-varying magnetic fields, resulting in congestion of blood vessels and consequently widening of the vascular wall. .
- the time-varying magnetic field directly affects blood vessels in vivo, causing various ions (Na +, K +, Cl-, etc.) in the blood vessels to stimulate blood vessel walls to increase blood volume.
- the time-varying magnetic field can dilate blood vessels by stimulating the bioions in the sympathetic nervous system that governs the arteries, capillaries, and smooth muscles of the vasculature.
- the effect of vasodilation can be obtained for both static and time-varying magnetic fields, but in the case of time-varying magnetic fields, various ions (Na +, K +, Cl-, etc.) in the blood vessels may stimulate the vessel wall, or small arteries and capillaries, By stimulating the bio ions in the sympathetic nervous system that manages smooth muscle of the washing veins, and by expanding the blood vessels, more effective wound healing can be obtained.
- various ions Na +, K +, Cl-, etc.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
The present invention relates to a medical band, and specifically, the medical band according to the present invention comprises a band member which is applied on at least a portion of the human body and is biased elastically. According to the present invention, by using the band member which is biased elastically, and a pair of magnet parts which is attached to the band member and has attractive force produced by a magnetic field, additional retaining force applying in the suturing direction of a wound is provided, thereby enabling the minimization of the phenomenon of wound-widening due to skin tension.
Description
본 발명은 의료용 밴드에 관한 것으로서, 창상 등의 치료에 유용한 밴드 타입의 의료 용품에 관한 것이다.BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to medical bands and to band-type medical supplies useful for the treatment of wounds and the like.
창상(상처, wound)이란 인체의 정상적인 조직(anatomy)이 파괴된 것을 말한다. 상처가 발생하면 인체내에서는 해당 상처를 치유하기 위해서 상처치유체계(wound healing system)와 면역시스템(immunologic system)이 동시에 작동된다.A wound is a breakdown of normal anatomy of the body. When a wound occurs, the wound healing system and the immune system work simultaneously in the body to heal the wound.
일단 발생된 상처는 원래의 정상적인 해부학적인 모습과 기능을 갖도록 복구시키는 것이 의학의 목표이다. 이를 위하여 발생된 상처는 최단 기간 내에 흉조직이 최소화 되고 일상적인 생활에 잘견딜 수 있는 내구성을 갖는 환경을 유지시켜 주는 것이 매우 중요하다. 흉조직은 상처가 서로 붙고 벌어지는 것을 막으며, 외부에서 균이나 이물질이 상처를 통하여 인체 내로 침투되는 것을 막는데 매우 중요한 역할을 하지만, 반면 흉조직이 필요이상으로 많이 만들어 질 경우 비후성반흔(hypertrophic scar) 또는 켈로이드가 발생하게 되고, 외형적인 추형으로 인해 심리적인 열등감등을 초래하고, 인체기능에도 부적절하게 된다. 또 흉조직이 골절된 뼈사이에 끼이거나 혈액순환이 좋지 않은 흉조직으로 둘러싸일 경우에는 뼈의 결합 또는 치유에도 역효과가 나타날 수 있다.Once the wound is intact, the goal of medicine is to restore it to its normal anatomical appearance and function. To this end, it is very important for the wounds to be maintained in the shortest period of time to maintain a durable environment that can minimize the chest tissue and withstand daily life. Thoracic tissue plays a very important role in preventing wounds from sticking together and spreading, and prevents germs and foreign substances from penetrating into the body through the wound, whereas hypertrophic scar ) Or keloids are generated, and the appearance of the vertebrae causes psychological inferiority, and is inappropriate for human function. In addition, when the chest tissue is sandwiched between fractured bones or surrounded by poorly circulated chest tissues, adverse effects may also occur in the bonding or healing of the bones.
이러한 이유로 피부등 연부조직에 발생하는 흉조직을 최대한 줄이면서도 내구성은 충분히 갖도록 기능하는 다양한 드레싱 재료가 개발되어 왔다. 대표적으로 자가 삼출물을 그대로 유지 이용하여 습윤한 상태를 지속적으로 제공하는 재료들이 많이 이용되고 있다. 그러나 흉조직을 최소화할 수 있는 치료(scarless wound healing)를 위해서는 상처의 양단에 걸리는 긴장(벌어지려는)을 최소화시키는 것이 가장 중요한데 단순히 봉합사만으로 끌어 당겨 이를 해결하고자 한다면 수상후 수일간 지속되는 부종으로 인한 더 높아지는 조직압력과 이에 저항하는 봉합사간에 피할 수 없는 스티치 마크(stitch mark)로 인한 새로운 흉터와 조직압력에 따른 혈액순환의 감소/차단등으로 인한 상처치유의 지연, 더 많은 흉조직의 발생 및 이차적인 감염 등을 감수해야 하게 된다.For this reason, various dressing materials have been developed that function to have sufficient durability while minimizing chest tissue occurring in soft tissues such as skin. Representatively, many materials are used to continuously provide a wet state by using and maintaining self-exudates. However, for scarless wound healing, it is most important to minimize the tension on both ends of the wound. If you simply drag the suture to fix it, it may be a swelling that lasts for several days after the injury. Delays in wound healing due to new scars and tissue pressures that reduce or block blood circulation due to higher tissue pressure and inevitable stitch marks between the sutures that resist it, the development of more chest tissue, and You will have to take secondary infections.
본 발명은 상처의 피부의 긴장에 따른 상처가 벌어지려는 것을 최대한 방지할 수 있는 의료용 밴드를 제공한다.The present invention provides a medical band that can be prevented as much as possible to open the wound caused by the tension of the skin of the wound.
또한 본 발명은 인체의 상처 치유 시스템을 활발히 유도가 가능한 의료용 밴드를 제공한다.The present invention also provides a medical band capable of actively inducing the human wound healing system.
동시에 본 발명은 자가 삼출물을 그대로 유지 및 이용하여 습윤 상태를 지속적으로 유지시킬 수 있는 의료용 밴드를 제공한다.At the same time, the present invention provides a medical band that can maintain a wet state by using and maintaining the self-exudation as it is.
본 발명에 따른 의료용 밴드는 인체의 적어도 일부에 적용되고, 편향적인 탄성을 구비하는 밴드부재를 포함한다.Medical band according to the present invention is applied to at least a portion of the human body, and includes a band member having a biased elasticity.
또한 상기 밴드부재에 상호 역방향의 자기장을 형성하도록 배열되는 한 쌍의 막대형 자석부재;를 포함할 수 있다.It may also include; a pair of bar-shaped magnet member arranged to form a magnetic field in the opposite direction to the band member.
또한 상기 한 쌍의 자석부재는 일정 간격 이격되어 평행하게 구비될 수 있다.In addition, the pair of magnet members may be provided in parallel with a predetermined interval spaced apart.
*또한 상기 자석부재는 상기 밴드부재가 인체에 부착되기 위한 부착면, 상기 밴드부재의 부착면의 타측면 및 상기 밴드부재의 내부 중 어느 하나의 위치에 구비될 수 있다.The magnet member may be provided at any one of an attachment surface for attaching the band member to a human body, another side surface of the attachment surface of the band member, and an inside of the band member.
또한 상기 밴드부재의 적어도 일부는 상기 자석부재의 길이방향으로의 탄성과 상기 한 쌍의 자석부재의 배열방향으로의 탄성이 상이할 수 있다.In addition, at least a portion of the band member may have different elasticity in the longitudinal direction of the magnet member and elasticity in the arrangement direction of the pair of magnet members.
또한 상기 밴드부재는 상기 한 쌍의 자석부재의 배열방향으로는 탄성을 구비하고, 상기 자석부재의 길이 방향으로는 탄성이 없도록 형성될 수 있다.In addition, the band member may be formed to have elasticity in the arrangement direction of the pair of magnet members and not elastic in the longitudinal direction of the magnet member.
또한 상기 한 쌍의 자석부재 사이의 밴드부재는 상기 한 쌍의 자석부재의 배열방향으로도 탄성이 없는 비탄성부로 형성될 수 있다.In addition, the band member between the pair of magnet members may be formed of an inelastic portion having no elasticity in the arrangement direction of the pair of magnet members.
또한 상기 밴드부재의 일면에는 상기 한 쌍의 자석부재 사이에 인체의 상처에 적용되는 드레싱부재가 구비될 수 있다.In addition, one surface of the band member may be provided with a dressing member applied to the wound of the human body between the pair of magnet members.
또한 상기 밴드부재의 중앙부를 포함하는 적어도 일부 영역 및 상기 자석부재 사이에는 인체의 상처에 적용되는 드레싱부재가 일체형으로 구비될 수 있다.In addition, a dressing member applied to a wound of a human body may be integrally provided between at least a portion of the band member including the center portion and the magnet member.
또한 상기 밴드부재의 일면에 부착되고, 상기 드레싱부재의 이외의 영역에 대응하는 부분이 편향적 탄성을 갖도록 직조되는 외피부재가 더 포함될 수 있다.In addition, the cover member is attached to one surface of the band member, the portion corresponding to the region other than the dressing member may be further included a woven member having a biased elasticity.
또한 상기 드레싱부재는 항생제, 연고, 소염제, 진통제, 창상치유 성장인자, 호르몬, 스테로이드, 자가이식 세포 및 합성 조직재생 촉진제 중 적어도 어느 하나 이상을 포함할 수 있다.In addition, the dressing member may include at least one or more of antibiotics, ointments, anti-inflammatory agents, analgesics, wound healing growth factors, hormones, steroids, autologous cells and synthetic tissue regeneration promoters.
또한 상기 드레싱부재는 습윤 드레싱 제재로 형성될 수 있다.In addition, the dressing member may be formed of a wet dressing material.
또한 상기 드레싱부재는 하이드로콜로이드, 폴리우레탄 폼, 폴리우레탄 필름 및 하이드로겔 중 적어도 어느 하나의 재질로 형성된 레이어를 포함할 수 있다.In addition, the dressing member may include a layer formed of at least one of a hydrocolloid, a polyurethane foam, a polyurethane film, and a hydrogel.
또한 상기 드레싱부재는 카르복시메틸 셀룰로오스(carboxymethyl cellulose, CMC) 파우더 또는 상기 CMC 파우더를 포함하는 혼합물 중 어느 하나로 형성된 하이드로콜로이드 레이어를 포함할 수 있다.In addition, the dressing member may include a hydrocolloid layer formed of any one of carboxymethyl cellulose (CMC) powder or a mixture containing the CMC powder.
또한 상기 CMC 파우더 혼합물은 CMC 파우더와 젤라틴(Gelatin), 펙틴(Pectin), 알지네이트(alginate) 및 수지(gum) 중 적어도 어느 하나의 파우더의 혼합 및 고형화에 의하여 형성될 수 있다.In addition, the CMC powder mixture may be formed by mixing and solidifying CMC powder and powder of at least one of gelatin, gelatin, pectin, alginate, and resin.
또한 상기 고형화 시 상기 CMC 파우더 혼합물은 폴리이소부틸렌(polyisobutylene)에 의하여 접착될 수 있다.In addition, the CMC powder mixture may be adhered by polyisobutylene during solidification.
또한 상기 자석 부재는 영구 자석 및 전자석 중 어느 하나의 타입으로 구비될 수 있다.In addition, the magnet member may be provided as any one type of permanent magnet and electromagnet.
본 발명에 따르면 편향적인 탄성을 갖는 밴드부 및 밴드부에 부착되어 자기장에 의한 인력이 작용하는 한 쌍의 자석부를 이용함으로써 상처를 봉합하는 방향으로 작용하는 부가적인 유지력을 제공하여 피부의 긴장에 따라 상처가 벌어지려는 현상을 최소화할 수 있다.According to the present invention, by using a band portion having a deflected elasticity and a pair of magnet portions attached to the band portion and acting by a magnetic field, an additional holding force acting in the direction of suturing the wound is provided so that the wound may be in accordance with the tension of the skin. Minimize what's going to happen.
또한 본 발명에 따르면 다양한 인체의 성장인자들을 상처의 주위로 유도함으로써 인체의 상처 치유 시스템을 향상시킴으로써 상처의 효과적인 치료가 가능하도록 하는 효과가 있다.In addition, according to the present invention by inducing various growth factors of the human body around the wound has an effect of enabling the effective treatment of the wound by improving the wound healing system of the human body.
또한 본 발명에 따르면 다양한 드레싱제들을 포함하는 것이 가능하며, 상처를 습윤상태로 유지하여 상처의 회복이 더욱 효율적으로 이루어 질 수 있도록 하는 효과가 있다.In addition, according to the present invention it is possible to include a variety of dressing agents, there is an effect to maintain the wound in a wet state so that the recovery of the wound can be made more efficiently.
도 1은 본 발명의 일 실시예에 따른 의료용 밴드의 일측면의 모습을 나타내는 사시도이다.1 is a perspective view showing a state of one side of a medical band according to an embodiment of the present invention.
도 2는 본 발명의 일 실시예에 따른 의료용 밴드의 타측면을 나타내는 사시도이다.Figure 2 is a perspective view showing the other side of the medical band according to an embodiment of the present invention.
도 3은 다른 실시예에 따른 의료용 밴드의 모습을 나타내는 사시도이다.3 is a perspective view showing a state of the medical band according to another embodiment.
도 4는 또 다른 실시예에 따른 의료용 밴드의 모습을 나타내는 사시도이다.Figure 4 is a perspective view showing the state of the medical band according to another embodiment.
도 5는 자석의 타입이 변형된 실시예에 따른 의료용 밴드의 모습을 나타내는 사시도이다.5 is a perspective view showing a state of the medical band according to the embodiment in which the type of the magnet is modified.
도 6은 도 4의 의료용 밴드의 모습을 나타낸 측면도이다.6 is a side view showing a state of the medical band of FIG.
도 7은 도 4의 의료용 밴드를 환부에 적용한 예시적인 모습을 나타내는 개략도이다.FIG. 7 is a schematic view illustrating an example of applying the medical band of FIG. 4 to an affected part.
도 8은 또 다른 실시예에 따른 의료용 밴드를 나타내는 사시도이다.8 is a perspective view showing a medical band according to another embodiment.
도 9 내지 도 11은 각각 또 다른 실시예에 따른 의료용 밴드를 나타내는 사시도이다.9 to 11 are each a perspective view showing a medical band according to yet another embodiment.
도 12는 또 다른 실시예에 따라 직류 전원이 인가되는 전자석을 이용한 의료용 밴드를 나타내는 사시도이다.12 is a perspective view illustrating a medical band using an electromagnet to which DC power is applied according to another embodiment.
도 13은 또 다른 실시예에 따라 교류 전원이 인가되는 전자석을 이용한 의료용 밴드를 나타내는 사시도이다.13 is a perspective view illustrating a medical band using an electromagnet to which an AC power source is applied according to still another embodiment.
본 발명에 따른 의료용 밴드는 인체의 적어도 일부에 적용되고, 편향적인 탄성을 구비하는 밴드부재를 포함한다.Medical band according to the present invention is applied to at least a portion of the human body, and includes a band member having a biased elasticity.
이하 첨부된 도면을 참조하여 본 발명의 실시예를 설명한다. 특별한 정의나 언급이 없는 경우에 본 설명에 사용하는 방향을 표시하는 용어는 도면에 표시된 상태를 기준으로 한다. 또한 각 실시예를 통하여 동일한 도면부호는 동일한 부재를 가리킨다. 한편, 도면상에서 표시되는 각 구성은 설명의 편의를 위하여 그 두께나 치수가 과장될 수 있으며, 실제로 해당 치수나 구성간의 비율로 구성되어야 함을 의미하지는 않는다.Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings. Unless otherwise defined or mentioned, terms indicating directions used in the present description are based on the states shown in the drawings. In addition, the same reference numerals throughout the embodiments indicate the same member. On the other hand, each of the components shown in the drawings may be exaggerated in thickness or dimensions for the convenience of description, and does not mean that actually should be configured by the ratio between the dimensions or configurations.
도 1 내지 도 3을 참조하여 본 발명의 일 실시예에 따른 의료용 밴드를 설명한다. 도 1은 본 발명의 일 실시예에 따른 의료용 밴드의 부착면의 모습을 나타내는 사시도이고, 도 2는 본 발명의 일 실시예에 따른 의료용 밴드의 타측면을 나타내는 사시도이며, 도 3은 다른 실시예에 따른 의료용 밴드의 모습을 나타내는 사시도이다.A medical band according to an embodiment of the present invention will be described with reference to FIGS. 1 to 3. 1 is a perspective view showing the appearance of the mounting surface of the medical band according to an embodiment of the present invention, Figure 2 is a perspective view showing the other side of the medical band according to an embodiment of the present invention, Figure 3 is another embodiment Is a perspective view showing the state of the medical band according to.
본 발명의 일 실시예에 따른 밴드 부재(100)와 자석부재(210a, 210b)를 구비한다.The band member 100 and the magnet members 210a and 210b according to the exemplary embodiment of the present invention are provided.
밴드 부재(100)는 인체의 일부에 부착되어 상처의 보호, 드레싱 등의 기능을 수행하기 위한 부재이며, 자석 부재(210a, 210b)는 도 1에 도시된 바와 같이 밴드 부재(100)의 일면에 구비되어 인체의 창상의 치유를 돕는 기능을 수행한다. 본 실시예에서 밴드 부재(100)의 타측면에는 도 2에 도시된 바와 같이 별도의 구성이 구비되어 있지 않으며, 해당 타측면은 밴드 부재(100) 자체의 내구성이나 방오(anti-contamination)기능을 위한 레이어 또는 필름으로 형성될 수 있다. The band member 100 is a member attached to a part of the human body to perform a function of protecting a wound, dressing, and the like, and the magnet members 210a and 210b are formed on one surface of the band member 100 as shown in FIG. 1. It is provided to perform the function of helping the healing of the human wound. In the present embodiment, the other side of the band member 100 is not provided with a separate configuration as shown in FIG. 2, and the other side has the durability or anti-contamination function of the band member 100 itself. Can be formed into a layer or film.
구체적으로 본 실시예에 따른 자석 부재(210a, 210b)는 밴드 부재(100)의 일 측면에 서로 이격된 상태로 평행하게 배열된다. 이 때 자석 부재(210a, 210b)는 각 자석 부재(210a, 210b)의 극성이 서로 반대가 되어 역방향의 자기장을 형성하도록 구비되는 것이 바람직하다. 이러한 자석 부재(210a, 210b)의 배열로 인하여 두 자석 부재(210a, 210b)간에는 인력이 작용하게 된다.In detail, the magnet members 210a and 210b according to the present exemplary embodiment are arranged in parallel with each other on one side of the band member 100 while being spaced apart from each other. At this time, the magnet members 210a and 210b are preferably provided such that the polarities of the magnet members 210a and 210b are opposite to each other to form a reverse magnetic field. Due to the arrangement of the magnet members 210a and 210b, an attraction force acts between the two magnet members 210a and 210b.
한편, 자석 부재(210a, 210b)는 영구 자석과 전자석 등 어떠한 타입의 자석으로도 구현이 가능하다. 예를 들어 별도의 추가적인 부재없이 단순히 영구 자석만으로도 구비되는 것이 가능하며, 전력 입력 단자를 구비하는 전자석을 이용하여 구현하는 것도 가능하다. 즉, 본 발명에 따른 의료용 밴드에 포함되는 자석의 종류에는 제한이 없다.Meanwhile, the magnet members 210a and 210b may be implemented as any type of magnet such as a permanent magnet and an electromagnet. For example, it is possible to simply be provided only by a permanent magnet without any additional member, it is also possible to implement using an electromagnet having a power input terminal. That is, there is no limitation on the kind of magnet included in the medical band according to the present invention.
본 실시예에 따른 자석 부재(210a, 210b)의 기능 중 하나는 정상적인 혈관에 존재하는 적혈구를 끌어들여 창상 주위에 혈액내 산소분압을 높여주는 것인데, 이는 적혈구내에 헤모글로빈이 들어있고 이 헤모글로빈에는 Fe++/ Fe+++이 존재하기 때문이다. 이러한 방식으로 자석 부재(210a, 210b)는 자기장을 형성하여 적혈구를 창상 주위로 유도함으로써 혈관 자체가 크고 굵어지는 울혈현상이 나타나게 된다. 이로 인해 혈관벽의 구멍들이 커져서 정상적인 창상치유 및 면역체계에 관여하는 T, B, K 임파구들 및 백혈구와 monocyte, macrophage, platelet 등이 조직 내로 이동할 수 있게 되고 촉진될 수 있다. 또한 EGF, FGF, IGF, AGF, PDGF, BMP, TGF-β1, TGF-β2, TGF-β3, TGF-α, TNF-α, PDGF, FGF-1, FGF-2, FGF-4, FGF-7(KGF-1), FGF-10(KGF-2), EGF. IGF-1/Sm-C, IL-1α, IL-1β, CTGF, VEGF 등의 수많은 창상 치유 호르몬(wound healing hormone)과 성장인자들이 분비가 촉진됨으로써 창상의 치유기간을 더욱 단축시킬 수 있다.One of the functions of the magnet members 210a and 210b according to the present embodiment is to draw red blood cells present in normal blood vessels, thereby increasing oxygen partial pressure in the blood around the wound, which contains hemoglobin in the red blood cells, and the hemoglobin is Fe ++ /. Fe +++ exists. In this manner, the magnet members 210a and 210b form a magnetic field to guide red blood cells around the wound, thereby causing congestion of large and thick blood vessels themselves. This results in larger openings in the vessel wall, allowing T, B, K lymphocytes and leukocytes, monocytes, macrophages, and platelets, which are involved in normal wound healing and immune system, to move into and promote tissue. Also EGF, FGF, IGF, AGF, PDGF, BMP, TGF-β1, TGF-β2, TGF-β3, TGF-α, TNF-α, PDGF, FGF-1, FGF-2, FGF-4, FGF-7 (KGF-1), FGF-10 (KGF-2), EGF. Many wound healing hormones and growth factors, such as IGF-1 / Sm-C, IL-1α, IL-1β, CTGF, and VEGF, can be secreted to further shorten the healing period of wounds.
이외에도 자기장의 영향으로 혈액 및 체액 그리고 조직액들의 이동이 촉진된다. 즉 이들의 지속적인 생성과 자극이 동시에 이루어지게 되는데 이에 대한 연구자료는 널리 알려져 있으며, 또한 자기장은 피부 및 연부조직의 재생, 창상치료 촉진, 골절된 뼈의 유합(union) 및 재형성(remodeling)을 촉진한다고 수많은 보고들이 있다. 본 의료용 밴드(10)도 피부 및 연부조직 창상모델과 골절치료용 모델의 두 가지 모델로 모두 이용 가능하다.In addition, the magnetic field promotes the movement of blood, body fluids and tissue fluids. That is, their continuous production and stimulation are simultaneously performed, and research data on them are widely known, and the magnetic field is used for regeneration of skin and soft tissues, promoting wound healing, union and remodeling of fractured bones. There are numerous reports to promote. The medical band 10 is also available in both models of skin and soft tissue wound models and fracture treatment models.
본 실시예에 따른 밴드 부재(100)는 전체적으로 플레이트 형상으로 형성되고, 일면에는 자석 부재(210a, 210b)가 부착된다. 자석 부재(210a, 210b)는 일정 간격 이격된 상태로 부착됨으로써 밴드 부재(100)의 일면 중 일부(PH1)가 자석 부재(210a, 210b) 사이에서 외부로 노출된 상태가 된다. 이러한 일부의 영역(PH1)은 창상 등에 접촉하거나 창상에 대응하는 위치에 위치하여 창상이 외부와 격리되는 등 물리적으로 보호될 수 있도록 한다.The band member 100 according to the present embodiment is formed in a plate shape as a whole, and magnet members 210a and 210b are attached to one surface thereof. The magnet members 210a and 210b are attached to be spaced apart from each other by a predetermined interval so that a portion PH1 of one surface of the band member 100 is exposed to the outside between the magnet members 210a and 210b. Some of these areas PH1 may be physically protected, such as contact with the wound or at a position corresponding to the wound so that the wound is isolated from the outside.
또한 본 발명에 따른 밴드 부재(100)는 편향적 탄성을 갖도록 형성된다. 구체적으로 밴드 부재(100)는 자석부재(210a, 210b)의 길이 방향(D2-D2`)으로는 탄성을 갖지 않도록 형성되는 반면 자석부재(210a, 210b)의 배열 방향(D1-D1`)으로는 탄성을 갖도록 형성되는 것이 바람직하다. 이는 창상의 텐션(tension)을 감소시켜 데드 스페이스(dead space)를 최소화하는 기능을 수행한다. 이에 관하여는 이후 상세히 설명한다.In addition, the band member 100 according to the present invention is formed to have a deflection elasticity. Specifically, the band member 100 is formed so as not to have elasticity in the length direction (D2-D2`) of the magnet members (210a, 210b), while in the arrangement direction (D1-D1`) of the magnet members (210a, 210b). Is preferably formed to have elasticity. This reduces the tension on the window and minimizes dead space. This will be described later in detail.
한편, 밴드 부재(100) 중 창상에 대응하는 영역(PH1)은 드레싱 부재 등의 고정을 용이하게 할 수 있도록 비탄성적으로 형성되는 것도 가능하다.On the other hand, the region PH1 corresponding to the wound in the band member 100 may be formed inelastically to facilitate fixing of the dressing member or the like.
또한 밴드 부재(100)는 거즈형 또는 습윤 드레싱형 등으로 형성될 수 있다. 거즈형의 경우 자석 등의 부착이 용이하며, 직조를 통하여 편향적인 탄성을 갖도록 형성하는 것도 유리하다. 습윤 드레싱형으로 형성되는 경우 창상의 치유면에서 보다 유리한 효과를 얻을 수 있다. 이 때 밴드 부재(100)는 하이드로콜로이드, 폴리우레탄 폼, 폴리우레탄 필름 및 하이드로겔 중 적어도 어느 하나의 재질로 형성된 레이어를 포함할 수 있다.In addition, the band member 100 may be formed in a gauze type or a wet dressing type. In the case of a gauze type, it is easy to attach a magnet or the like, and it is also advantageous to form a biased elasticity through weaving. When formed in a wet dressing type, a more advantageous effect can be obtained in terms of healing of wounds. In this case, the band member 100 may include a layer formed of at least one material of hydrocolloid, polyurethane foam, polyurethane film, and hydrogel.
한편, 밴드 부재(100)가 자체적으로 탄성재질로 형성되거나, 거즈형인 경우에도 별도의 편향적인 탄성을 부여하기 위한 직조가 되어 있지 않은 경우에는 도 3에 도시된 바와 같이 비탄성 부재(140a, 140b)를 소정의 간격으로 배열하는 것이 가능하다. 예를 들어 길이 방향으로 제1 비탄성 부재(140a)가 일정 간격으로 배열되고, 제1 비탄성 부재(140a) 중 일부를 연결하는 제2 비탄성 부재(140b)를 배열할 수 있다.On the other hand, when the band member 100 is itself formed of an elastic material or is not woven to impart a separate deflection elasticity even in the case of a gauze type, the inelastic members 140a and 140b as shown in FIG. 3. It is possible to arrange the at predetermined intervals. For example, the first inelastic members 140a may be arranged at regular intervals in the longitudinal direction, and the second inelastic members 140b may be arranged to connect some of the first inelastic members 140a.
밴드 부재(100)가 탄성 재질로 형성되는 경우 제1 비탄성 부재(140a)만 배열된 부분은 길이 방향(D2-D2`)으로는 탄성이 없으나 폭 방향(D1-D1`)으로는 탄성을 갖게 되고, 제1 비탄성 부재(140a)와 제2 비탄성 부재(140b)가 겹쳐진 부분에는 어느 방향으로도 탄성이 최소화된 상태가 된다. 앞서 설명한 바와 같이 제1 비탄성 부재(140a)만 배열된 부분은 창상의 텐션을 감소시키는 작용을 하고, 제1 비탄성 부재(140a)와 제2 비탄성 부재(140b)가 겹쳐진 부분은 드레싱제 등의 부착을 용이하게 하는 기능을 한다.When the band member 100 is formed of an elastic material, the portion in which only the first non-elastic member 140a is arranged has no elasticity in the longitudinal direction D2-D2` but has elasticity in the width direction D1-D1`. The portion of the first non-elastic member 140a and the second non-elastic member 140b is in a state in which elasticity is minimized in any direction. As described above, the portion in which only the first inelastic member 140a is arranged serves to reduce the tension of the wound, and the portion in which the first inelastic member 140a and the second inelastic member 140b overlap with each other is attached with a dressing agent. To facilitate the function.
비탄성 부재(140a, 140b)는 밴드 부재(100)의 표면에 부착되는 방식으로 구비되거나 밴드 부재(100)의 내부에 구비되는 방식으로 구비될 수 있다.The inelastic members 140a and 140b may be provided in a manner of being attached to the surface of the band member 100 or provided in a manner of being provided inside the band member 100.
습윤 드레싱에 관하여는 이후 상세히 설명한다.Wet dressing is described in detail later.
도 4 내지 도 7을 참조하여 다른 실시예에 따른 의료용 밴드를 설명한다. 도 4는 또 다른 실시예에 따른 의료용 밴드의 모습을 나타내는 사시도이고, 도 5는 자석의 타입이 변형된 실시예에 따른 의료용 밴드의 모습을 나타내는 사시도이다. 또한 도 6은 도 4의 의료용 밴드의 모습을 나타낸 측면도이고, 도 7은 도 4의 의료용 밴드를 환부에 적용한 예시적인 모습을 나타내는 개략도이다.A medical band according to another embodiment will be described with reference to FIGS. 4 to 7. Figure 4 is a perspective view showing the state of the medical band according to another embodiment, Figure 5 is a perspective view showing the state of the medical band according to an embodiment in which the type of the magnet is modified. In addition, Figure 6 is a side view showing the state of the medical band of Figure 4, Figure 7 is a schematic diagram showing an exemplary appearance of applying the medical band of Figure 4 to the affected part.
본 실시예에 따른 의료용 밴드(10b)는 자석 부재(210a, 210b)들 사이에 별도의 드레싱부재(250)를 더 포함한다는 점에서 차이가 있다. 앞서 설명한 바와 같이 본 실시예에 따른 밴드 부재(100)는 드레싱부재(250)가 부착되는 영역은 탄성이 없는 것이 바람직하다.The medical band 10b according to the present embodiment has a difference in that it further includes a separate dressing member 250 between the magnet members 210a and 210b. As described above, the band member 100 according to the present embodiment preferably has no elasticity in the region to which the dressing member 250 is attached.
드레싱부재(250)는 거즈 또는 습윤드레싱 제재 등의 방식으로 구비될 수 있다. 또한 드레싱부재는 항생제, 연고, 소염제, 진통제, 창상치유 성장인자, 호르몬, 스테로이드, 자가이식 세포 및 합성 조직재생 촉진제 중 적어도 어느 하나 이상을 포함하여 창상의 치유를 보조하거나 그 효과를 증대시킬 수 있다. Dressing member 250 may be provided in a manner such as gauze or wet dressing material. In addition, the dressing member may include at least one or more of antibiotics, ointments, anti-inflammatory agents, analgesics, wound healing growth factors, hormones, steroids, autologous cells, and synthetic tissue regeneration accelerators to assist or enhance the healing of wounds. .
구체적으로 드레싱부재(250)는 하이드로콜로이드, 폴리우레탄 폼, 폴리우레탄 필름 및 하이드로겔 중 어느 하나의 타입으로 형성되는 레이어를 포함할 수 있으며, 이러한 레이어들은 목적에 따라 도 6에 도시된 바와 같이 다층(251, 253, 255)으로 구성되는 것도 가능하다.Specifically, the dressing member 250 may include a layer formed of any one type of hydrocolloid, polyurethane foam, polyurethane film, and hydrogel, and these layers may be multilayered as shown in FIG. 6 according to the purpose. It is also possible to comprise (251, 253, 255).
하이드로콜로이드 레이어는 카르복시메틸 셀룰로오스(carboxymethyl cellulose, CMC) 파우더 또는 상기 CMC 파우더를 포함하는 혼합물 중 어느 하나로 형성될 수 있으며, CMC 파우더 혼합물은 CMC 파우더와 젤라틴(Gelatin), 펙틴(Pectin), 알지네이트(alginate) 및 수지(gum) 중 적어도 어느 하나의 파우더의 혼합 및 고형화에 의하여 형성될 수 있다. 이 때 고형화 시 CMC 파우더 혼합물은 폴리이소부틸렌(polyisobutylene)에 의하여 접착될 수 있다. 이외에도 PVA(polyvinyl alcohol), PVAc(polyvinyl acetate) 등을 이용한 하이드로겔 레이어를 형성하는 것도 가능하다.The hydrocolloid layer may be formed of any one of carboxymethyl cellulose (CMC) powder or a mixture containing the CMC powder, and the CMC powder mixture may be CMC powder, gelatin, pectin, alginate It may be formed by mixing and solidifying the powder of at least one of the resin and (gum). At this time, the CMC powder mixture may be bonded by polyisobutylene during solidification. In addition, it is also possible to form a hydrogel layer using PVA (polyvinyl alcohol), PVAc (polyvinyl acetate), and the like.
예를 들어 도 6에 도시된 바와 같이 드레싱부재(250)는 폴리우레탄 필름(251), 폴리우레탄 폼(253) 및 하이드로콜로이드 레이어(255)와 같이 형성될 수 있다. 하이드로콜로이드 레이어(255)는 삼출액을 빠르게 흡수하여 젤화 된다. 또한 폴리우레탄 폼(253)은 친수성으로서 삼출액을 흡수하고 폴리우레탄 필름(251)과 함께 상처 치유 환경을 조성한다.For example, as illustrated in FIG. 6, the dressing member 250 may be formed together with the polyurethane film 251, the polyurethane foam 253, and the hydrocolloid layer 255. The hydrocolloid layer 255 is gelated by quickly absorbing the exudates. In addition, the polyurethane foam 253 is hydrophilic and absorbs the exudates and together with the polyurethane film 251 creates a wound healing environment.
한편, 자석 부재(210a, 210b)의 극성은 형성되는 자기장이 역방향을 유지하는 한 다양한 형태로 배열될 수 있다. 예를 들어 도 5에 도시된 바와 같이 길이 방향으로 극성이 다른 자석이 아니라, 상부면과 하부면의 극성이 다른 타입의 자석을 이용하는 것도 가능하다. 이 경우 두 자석 부재(210a, 210b)간에는 인력이 작용하는 것은 자명하나, 그 이전에 두 자석 부재(210a, 210b)들은 각각 다른 극성의 면이 서로 마주하려는 회전력이 더 크게 작용한다. 이러한 두 자석 부재(210a, 210b)의 회전력은 자석 부재(210a, 210b)들이 앞서 설명한 실시예들에 비하여 창상 주위의 인체를 비교적 깊이 눌러줌으로써 두 자석 부재간의 인력과 함께 작용하여 창상의 양단면에 작용하는 텐션을 감소시키는 작용 및 효과를 더 증가시킬 수 있다.Meanwhile, the polarities of the magnet members 210a and 210b may be arranged in various forms as long as the magnetic field formed therein maintains the reverse direction. For example, as shown in FIG. 5, it is also possible to use a magnet of a type having a different polarity between the upper and lower surfaces instead of the magnet having a different polarity in the longitudinal direction. In this case, it is obvious that the attraction force acts between the two magnet members 210a and 210b, but before that, the two magnet members 210a and 210b have a greater rotational force to face each other with different polarities. The rotational force of the two magnet members 210a and 210b acts together with the attraction force between the two magnet members by pressing the human body around the wound relatively deeply compared to the embodiments described above. It can further increase the action and effect of reducing the tension acting.
도 6 및 도 7을 참조하여 설명하면, 앞서 설명한 바와 같이 밴드부재(100)는 탄성영역(PH1b)과 비탄성영역(PH1a)으로 구분되도록 형성될 수 있다. 비탄성영역(PH1a)에는 드레싱부재(250)가 고정되어 창상을 보호할 수 있으며, 탄성영역(PH1b)은 인체에 부착되어 자석부재(210a, 210b)를 포함하는 의료용 밴드(10b) 전체를 인체에 고정시키는 기능을 한다.Referring to FIGS. 6 and 7, as described above, the band member 100 may be formed to be divided into an elastic region PH1b and an inelastic region PH1a. The dressing member 250 is fixed to the inelastic region PH1a to protect the wound, and the elastic region PH1b is attached to the human body so that the entire medical band 10b including the magnet members 210a and 210b is attached to the human body. Function to fix.
이 때 비탄성영역(PH1b)은 인체에 부착되지 않고 탄성도 없기 때문에 인체를 당겨주거나 인체에 작용하는 텐션에 영향을 미치지는 않는다. 이에 비하여 제1 지점(P1) 및 제2 지점(P2)를 기준으로 외측으로는 인체에 부착된 상태이며 탄성을 구비하기 때문에 인체를 중심방향으로 잡아 당겨주는 효과를 얻을 수 있다.At this time, the inelastic region PH1b does not attach to the human body and has no elasticity, and thus does not affect the tension applied to the human body or acting on the human body. Compared to the first point P1 and the second point P2, the outer side is attached to the human body and has elasticity, thereby pulling the human body toward the center.
피부 및 연부조직의 최소흉 창상 치료(scarless wound healing)를 하기 위해서는 첫째, 창상 양 단면에 걸리는 긴장(tension)을 최소화 하면서 양 단면 사이의 사강(dead space)를 최소화 시켜야 하며, 둘째, 창상의 치료기간을 최소화하기 위하여 충분한 산소 및 영양의 공급이 원활하게 이루어 질 수 있도록 혈액공급이 활성화 되어야 하며, 셋째, 상처 치료에 직접적으로 관여하는 호르몬 및 성장인자들, 구체적으로는 EGF, FGF, IGF, AGF, PDGF, BMP, TGF-β1, TGF-β2, TGF-β3, TGF-α, TNF-α, PDGF, FGF-1, FGF-2, FGF-4, FGF-7(KGF-1), FGF-10(KGF-2), EGF. IGF-1/Sm-C, IL-1α, IL-1β, CTGF, VEGF 등이 최단기간에 충분히 공급되도록 하는 것이 매우 중요하다.In order to perform scarless wound healing of skin and soft tissues, firstly, the dead space between the two sections should be minimized while minimizing the tension between the two sections of the wound. In order to minimize the period of time, blood supply should be activated so that sufficient oxygen and nutrients can be supplied smoothly. Third, hormones and growth factors directly involved in wound healing, specifically, EGF, FGF, IGF, and AGF. , PDGF, BMP, TGF-β1, TGF-β2, TGF-β3, TGF-α, TNF-α, PDGF, FGF-1, FGF-2, FGF-4, FGF-7 (KGF-1), FGF- 10 (KGF-2), EGF. It is very important to ensure that IGF-1 / Sm-C, IL-1α, IL-1β, CTGF, VEGF, etc. are supplied sufficiently in the shortest period.
그 중에서도 피부에 발생한 창상에서는 창상 주위의 텐션(tension) 을 얼마나 효율적으로 줄이면서 이러한 사강(dead space)을 최소화하느냐가 가장 중요하다.Among the wounds on the skin, the most important thing is how to effectively reduce the dead space while reducing the tension around the wound.
도 7에 도시된 바와 같이 본 실시예에 따른 의료용 밴드(10b)를 인체의 창상(W)에 적용하는 경우 창상(W)에는 밴드 부재(100)의 탄성에 의한 응집력과 자석부재(210a, 210b)의 자기장에 따른 인력이 함께 작용하여 창상(W)의 양단면을 벌어지도록 하는 텐션을 상쇄시킨다. 반면, 앞서 설명한 바와 같이 창상의 길이 방향으로는 밴드 부재(100)의 탄성과 자석 부재(210a, 210b)의 인력이 작용하지 않기 때문에 인체의 텐션이 그대로 유지되며, 창상(W)의 양단면을 벌어지지 않도록 하기 위하여 필요한 힘 외의 불필요한 외력이 작용되지 않는다.As shown in FIG. 7, when the medical band 10b according to the present embodiment is applied to the wound W of the human body, the wound W has a cohesive force due to the elasticity of the band member 100 and the magnet members 210a and 210b. The attraction force according to the magnetic field of) acts together to offset the tension to open the both ends of the wound (W). On the other hand, as described above, since the elasticity of the band member 100 and the attraction force of the magnet members 210a and 210b do not act in the longitudinal direction of the wound, the tension of the human body is maintained as it is, and both end surfaces of the wound W are Unnecessary external forces other than the force necessary to prevent the opening does not work.
특히 이러한 탄성에 따른 응집력과 자기장에 의한 인력은 제1 지점(P1) 및 제2 지점(P2)의 외측에서만 작용하기 때문에 직접적으로 창상(W)의 형상을 변화시키거나 힘을 가하지 않아 효과적인 상처 치유 환경 조성에 유리하다.In particular, the cohesion force due to the elasticity and the attraction force due to the magnetic field act only on the outside of the first point P1 and the second point P2, so that the wound W is not changed or applied directly, thereby effectively healing the wound. It is advantageous for environmental composition.
한편, 도 8에 도시된 바와 같이 자석 부재(210a`, 210b`)는 밴드 부재(100)의 상부, 즉 부착면에 구비되는 드레싱 부재(250)의 타측면에 구비될 수 있다. 이 경우 자석 부재(210a`, 210b`)의 작용 및 효과는 그대로 유지하면서도 자석 부재(210a`. 210b`)가 인체에 직접 접촉하지 않도록 함으로써 자석 부재(210a`, 210b`)가 인체를 자극하거나 자석 부재(210a`, 210b`)가 창상으로부터의 삼출액으로 인하여 부식 또는 오염되는 것을 방지할 수 있다. 또한 밴드 부재(100)의 접착면을 창상의 크기 및 종류 등에 따라 다양하게 구성할 수 있는 장점이 있다.Meanwhile, as shown in FIG. 8, the magnet members 210a ′ and 210b ′ may be provided on the upper side of the band member 100, that is, on the other side of the dressing member 250 provided on the attachment surface. In this case, the magnet members 210a` and 210b` may stimulate the human body by preventing the magnet members 210a` and 210b` from directly contacting the human body while maintaining the functions and effects of the magnet members 210a` and 210b`. The magnet members 210a 'and 210b' can be prevented from being corroded or contaminated due to the effluent from the wound. In addition, there is an advantage that the adhesive surface of the band member 100 can be variously configured according to the size and type of the wound.
도 9 내지 도 11을 참조하여 다양한 실시예에 따른 의료용 밴드를 설명한다. 도 9 내지 도 11은 각각 또 다른 실시예에 따른 의료용 밴드를 나타내는 사시도이다.A medical band according to various embodiments will be described with reference to FIGS. 9 through 11. 9 to 11 are each a perspective view showing a medical band according to yet another embodiment.
도 9를을 참조하여 설명하면, 일 실시예에 따른 의료용 밴드(10d)는 자석 부재(210a, 210b)가 밴드 부재(100d)의 내부에 포함된다는 점에서 특징이 있다. 예를 들어 밴드 부재(100d)의 직조 또는 제조 과정 중 자석 부재(210a, 210b)가 내부에 구비되도록 할 수 있다. 이 경우 자석 부재(210a, 210b)와 피부가 직접 접촉하지 않도록 하면서, 자석 부재(210a, 210b)들 사이의 영역(PH1)뿐 아니라 밴드 부재(100d)와 인체가 접촉하는 면 전체를 창상 치유에 유리한 부재 및 재료 등을 적용하는 것이 가능하면서도, 자석 부재(210a, 210b)에 의한 창상의 텐션 상쇄 효과를 동일하게 얻을 수 있다는 장점이 있다.Referring to FIG. 9, the medical band 10d according to the exemplary embodiment is characterized in that the magnet members 210a and 210b are included in the band member 100d. For example, the magnet members 210a and 210b may be provided inside during the weaving or manufacturing process of the band member 100d. In this case, while the skin of the magnet members 210a and 210b does not come into direct contact with each other, not only the area PH1 between the magnet members 210a and 210b but also the entire surface of the band member 100d in contact with the human body for wound healing. While it is possible to apply an advantageous member, material and the like, there is an advantage that the tension canceling effect of the wound by the magnet members 210a and 210b can be obtained in the same manner.
이 경우 밴드 부재(100d)의 재질에는 특별한 제한이 없다. 즉, 거즈형이나 습식 드레싱 제재형 등 다양한 재질을 이용하는 것이 가능하다. 따라서 본 실시예의 경우 별도의 드레싱 부재를 부착하지 않아도 밴드 부재(100d) 자체를 드레싱 부재(습식 드레싱 제재) 일체형으로 구현하는 것이 가능하다.In this case, the material of the band member 100d is not particularly limited. That is, it is possible to use various materials, such as a gauze type or a wet dressing material type. Therefore, in the present embodiment, it is possible to implement the band member 100d itself as a dressing member (wet dressing material) without having to attach a separate dressing member.
도 10를 참조하여 설명하면, 다른 실시예로서 의료용 밴드(10e)는 밴드 부재(100)가 일체형이면서도 기능적 및 재질면에서 세 부분으로 구분되도록 제조될 수 있다. 구체적으로, 본 실시예에 따른 밴드 부재(100e)는 폭 방향을 기준으로 중앙의 드레싱부(151)와 양 측면의 접착부(153)의 세 부분으로 구분된다. 드레싱부(151)는 앞서 설명한 실시예 들의 드레싱 부재와 동일한 재질로 형성될 수 있으며, 창상에 직접 접촉하여 상처 치유 환경을 조성하는 기능을 한다. 양측의 접착부(153)들은 자석부재(210a, 210b)들을 내포하거나 상단 또는 하단에 부착된 상태로 인체에 부착되어 고정시키는 역할을 수행한다. 이 때 접착부(153) 들이 폭방향으로만 탄성을 갖도록 형성되는 것이 가능하다는 것은 앞서 설명한 실시예들과 동일하다.Referring to FIG. 10, as another embodiment, the medical band 10e may be manufactured so that the band member 100 is divided into three parts in one piece but functional and material. Specifically, the band member 100e according to the present exemplary embodiment is divided into three parts, the dressing part 151 at the center and the adhesive part 153 at both sides, based on the width direction. Dressing unit 151 may be formed of the same material as the dressing members of the above-described embodiments, and serves to directly contact the wound to create a wound healing environment. The adhesive parts 153 on both sides are attached to the human body in a state of enclosing the magnet members 210a and 210b or attached to the upper or lower ends. In this case, the adhesive parts 153 may be formed to have elasticity only in the width direction, as in the above-described embodiments.
도 11을 참조하여 설명하면, 또 다른 실시예로서, 밴드부재(151, 153)의 인체에 부착되지 않는 일면에 부착되는 외피부재(150)가 더 포함될 수 있다. 외피부재(150)는 밴드부재(151, 153) 들의 부착을 용이하게 하고 방오 기능을 부가하며, 내구성을 증가시키는 등의 기능을 할 수 있다. 또한 드레싱부(151) 이외의 영역, 즉 접착부(153)에만 편향적인 탄성을 갖도록 함으로써 빠른 상처 치유가 가능하도록 돕는 기능을 수행할 수 있다.Referring to FIG. 11, as another embodiment, an outer skin member 150 may be further included on one surface of the band members 151 and 153 that is not attached to the human body. The outer shell member 150 may serve to facilitate the attachment of the band members 151 and 153, add an antifouling function, and increase durability. In addition, by having a biased elasticity in only the region other than the dressing portion 151, that is, the adhesive portion 153, a function of helping rapid wound healing may be performed.
도 12 및 도 13을 참조하여 전자석을 구비한 의료용 밴드의 실시예들을 설명한다. 도 12는 또 다른 실시예에 따라 직류 전원이 인가되는 전자석을 이용한 의료용 밴드를 나타내는 사시도이고, 도 13은 또 다른 실시예에 따라 교류 전원이 인가되는 전자석을 이용한 의료용 밴드를 나타내는 사시도이다.12 and 13, embodiments of a medical band having an electromagnet will be described. FIG. 12 is a perspective view illustrating a medical band using an electromagnet to which DC power is applied according to still another embodiment, and FIG. 13 is a perspective view illustrating a medical band using an electromagnet to which AC power is applied according to another embodiment.
먼저 도 12는 자석 부재(213a, 213b)를 전자석으로 구현한 경우에 관한 것으로서 자석 부재(213a, 213b)를 작동시키기 위하여 직류 전원을 인가하였다. 이 경우 전류가 도선(215)을 통하여 제1 자석 부재(213b)와 제2 자석 부재(213a)를 순차적으로 경유하여 회귀하게 된다.First, FIG. 12 illustrates a case in which the magnet members 213a and 213b are implemented by electromagnets, and DC power is applied to operate the magnet members 213a and 213b. In this case, the current returns through the conductive line 215 via the first magnet member 213b and the second magnet member 213a sequentially.
제1 자석 부재(213b)와 제2 자석 부재(213a)는 각각 도선(215)을 이용하여 동일한 방향으로 권취하여 형성되었으며, 제1 자석 부재(213b)는 직류 전원(500)으으부터 입력되는 전류에 의하여 작동하고, 제2 자석 부재(213a)는 직류 전원(500)으로 회귀하는 전류에 의하여 작동되기 때문에 제1 자석 부재(213b)와 제2 자석 부재(213a)의 극성은 서로 역방향으로 형성된다. 따라서 제1 자석 부재(213b)와 제2 자석 부재(213a) 사이에는 앞서 설명한 영구 자석과 마찬가지로 인력이 작용하는 상태가 된다.Each of the first magnet member 213b and the second magnet member 213a is formed by winding in the same direction using the conductive wire 215, and the first magnet member 213b is a current input from the DC power supply 500. And the second magnet member 213a is operated by a current returning to the DC power supply 500, so that the polarities of the first magnet member 213b and the second magnet member 213a are formed in opposite directions. . Therefore, like the permanent magnet described above, the attraction force acts between the first magnet member 213b and the second magnet member 213a.
한편, 도 13에 도시된 바와 같이 제1 자석 부재(213b)와 제2 자석 부재(213a)에 교류 전원을 인가하여 제1 자석 부재(213b)와 제2 자석 부재(213a)의 주변에 시변 자기장이 형성되도록 하는 것도 가능하다. 이 경우 교류 전원으로는 사인파형 또는 펄스형 등 다양한 교류전원을 인가할 수 있다. 사인파나 펄스형 전원이 인가되는 경우 두 자석 부재(213a, 213b) 사이에는 크기가 주기적으로 변동하는 인력이 인가되며, 이에 따라 창상의 주위에는 체액 및/또는 혈액의 순환이 유도된다. 즉, 교류전원(510)에 의하여 자석 부재(213a, 213b)에 시변 자기장이 유도되면, 창상 주위에 시변 자기장이 형성됨으로써 다이나모 효과(dynamo effect)에 따라 D3-D3`방향으로 또는 그 역방향으로 혈액의 순환(circulation)이 촉진된다. 이는 새로운 혈액의 공급 등에 기여할 뿐 아니라 상처 치료에 직접적으로 관여하는 호르몬 및 성장인자들을 창상 주위에 충분히 공급되도록 하는 작용을 한다.Meanwhile, as illustrated in FIG. 13, an AC power is applied to the first magnet member 213b and the second magnet member 213a so that the time-varying magnetic field is around the first magnet member 213b and the second magnet member 213a. It is also possible to allow this to be formed. In this case, various AC power sources such as sine wave or pulse type can be applied as AC power. When a sine wave or pulse type power is applied, an attractive force is periodically applied between the two magnet members 213a and 213b, thereby circulating the body fluid and / or blood around the wound. That is, when the time-varying magnetic field is induced to the magnet members 213a and 213b by the AC power supply 510, the time-varying magnetic field is formed around the wound, so that the blood in the D3-D3` direction or the reverse direction is changed according to the dynamo effect. The circulation of is promoted. This not only contributes to the supply of new blood but also acts to ensure sufficient supply of hormones and growth factors directly involved in wound healing around the wound.
한편, 상술한 다양한 실시예들에 따른 자석 부재의 효과는 다음과 같이 정리 될 수 있다. 창상의 주변에 자기장을 형성시키는 경우, 혈관확장이 일어나고 이에 따라 혈관세포간 간극이 확장됨으로써 여러가지 염증세포가 창상부위에 활발히 유입되는 효과를 얻을 수 있다. 그 결과로서 면역체계가 활성화되고 창상치유호르몬 및 성장인자들이 짧은 시간 내에 다량 공급되어 창상치유가 빨라질 수 있다. On the other hand, the effect of the magnet member according to the above various embodiments can be summarized as follows. In the case of forming a magnetic field around the wound, vasodilation occurs and thus the gap between the vascular cells is expanded, so that various inflammatory cells can be actively introduced into the wound site. As a result, the immune system is activated, and wound healing hormones and growth factors are supplied in a large amount in a short time, so that wound healing can be accelerated.
구체적으로 이러한 혈관확장의 기전으로는 3가지가 고려된다.Specifically, three kinds of mechanisms of vasodilation are considered.
첫째, 정적 자기장 및 시변 자기장 모든 경우에 대하여 Fe++/Fe+++을 함유하고 있는 헤모글로빈을 포함하는 적혈구들이 자기장내로 응집하게 되고, 이에 따른 혈관의 울혈현상이 나타나며 그 결과로서 혈관벽사이의 간격이 더 넓어진다.First, erythrocytes containing hemoglobin containing Fe ++ / Fe +++ are aggregated into the magnetic field for both static and time-varying magnetic fields, resulting in congestion of blood vessels and consequently widening of the vascular wall. .
둘째, 시변 자기장은 생체내에서 혈관에 직접적인 영향을 주어 혈관내의 여러 이온들(Na+, K+, Cl-등)이 혈관벽을 자극하여 혈관확장으로 혈액량이 증가하도록 한다.Second, the time-varying magnetic field directly affects blood vessels in vivo, causing various ions (Na +, K +, Cl-, etc.) in the blood vessels to stimulate blood vessel walls to increase blood volume.
셋째, 시변 자기장은 소동맥과 모세혈관, 세정맥의 평활근 등을 관장하는 교감신경계에 들어있는 생체이온들을 자극하여 혈관을 확장시킬수 있다. Third, the time-varying magnetic field can dilate blood vessels by stimulating the bioions in the sympathetic nervous system that governs the arteries, capillaries, and smooth muscles of the vasculature.
즉, 정적 자기장이나 시변 자기장 모두에 대하여 혈관 확장의 효과를 얻을 수 있으나, 특히 시변 자기장의 경우에는 혈관내의 여러이온들(Na+, K+, Cl-등)이 혈관벽을 자극하도록 하거나 소동맥과 모세혈관, 세정맥의 평활근 등을 관장하는 교감신경계에 들어있는 생체이온들을 자극하여 혈관을 확장시킴으로써 더욱 활발한 창상 치유효과를 얻을 수 있다.In other words, the effect of vasodilation can be obtained for both static and time-varying magnetic fields, but in the case of time-varying magnetic fields, various ions (Na +, K +, Cl-, etc.) in the blood vessels may stimulate the vessel wall, or small arteries and capillaries, By stimulating the bio ions in the sympathetic nervous system that manages smooth muscle of the washing veins, and by expanding the blood vessels, more effective wound healing can be obtained.
이외에도 정적 자기장 및 시변 자기장이 인체에 미치는 영향에 대한 다양한이론 및 가설들이 존재하며, 이들 이론에 의하더라도 본 실시예에 따른 의료용 밴드가 창상 치유에 긍정적인 영향을 미치는 것은 자명하다.In addition, there are various theories and hypotheses about the effects of static and time-varying magnetic fields on the human body, and it is clear from these theories that the medical band according to the present embodiment has a positive effect on wound healing.
이상 본 발명의 바람직한 실시예에 대하여 설명하였으나, 본 발명의 기술적 사상이 상술한 바람직한 실시예에 한정되는 것은 아니며, 특허청구범위에 구체화된 본 발명의 기술적 사상을 벗어나지 않는 범주에서 다양하게 구현될 수 있다.Although the preferred embodiment of the present invention has been described above, the technical idea of the present invention is not limited to the above-described preferred embodiment, and may be variously implemented in a range without departing from the technical idea of the present invention specified in the claims. have.
Claims (17)
- 인체의 적어도 일부에 적용되고, 편향적인 탄성을 구비하는 밴드부재;를 포함하는 의료용 밴드.Medical band comprising a; band member applied to at least a part of the human body, the band member having a biased elasticity.
- 제1항에 있어서,The method of claim 1,상기 밴드부재에 상호 역방향의 자기장을 형성하도록 배열되는 한 쌍의 막대형 자석부재;를 포함하는 의료용 밴드.And a pair of bar-shaped magnet members arranged to form mutually opposite magnetic fields in the band member.
- 제2항에 있어서,The method of claim 2,상기 한 쌍의 자석부재는 일정 간격 이격되어 평행하게 구비되는 의료용 밴드.The pair of magnet members are medical bands provided in parallel with a predetermined interval apart.
- 제1항에 있어서,The method of claim 1,상기 자석부재는 상기 밴드부재가 인체에 부착되기 위한 부착면, 상기 밴드부재의 부착면의 타측면 및 상기 밴드부재의 내부 중 어느 하나의 위치에 구비되는 의료용 밴드.The magnet member is a medical band provided at any one of the attachment surface for attaching the band member to the human body, the other side of the attachment surface of the band member and the inside of the band member.
- 제1항에 있어서,The method of claim 1,상기 밴드부재의 적어도 일부는 상기 자석부재의 길이방향으로의 탄성과 상기 한 쌍의 자석부재의 배열방향으로의 탄성이 상이한 의료용 밴드.At least a portion of the band member is a medical band is different in elasticity in the longitudinal direction of the magnet member and the alignment direction of the pair of magnet members.
- 제5항에 있어서,The method of claim 5,상기 밴드부재는 상기 한 쌍의 자석부재의 배열방향으로는 탄성을 구비하고, 상기 자석부재의 길이 방향으로는 탄성이 없도록 형성되는 의료용 밴드.The band member is provided with elastic in the arrangement direction of the pair of magnet members, the medical band is formed so that there is no elasticity in the longitudinal direction of the magnet member.
- 제6항에 있어서,The method of claim 6,상기 한 쌍의 자석부재 사이의 밴드부재는 상기 한 쌍의 자석부재의 배열방향으로도 탄성이 없는 비탄성부로 형성되는 의료용 밴드.The band member between the pair of magnet members is a medical band formed of an inelastic portion that is not elastic in the arrangement direction of the pair of magnet members.
- 제1항에 있어서,The method of claim 1,상기 밴드부재의 일면에는 상기 한 쌍의 자석부재 사이에 인체의 상처에 적용되는 드레싱부재가 구비되는 의료용 밴드.One side of the band member is a medical band provided with a dressing member applied to the wound of the human body between the pair of magnet members.
- 제1항에 있어서,The method of claim 1,상기 밴드부재의 중앙부를 포함하는 적어도 일부 영역 및 상기 자석부재 사이에는 인체의 상처에 적용되는 드레싱부재가 일체형으로 구비되는 의료용 밴드.Medical bands are integrally provided between the at least some region including the central portion of the band member and the magnet member, the dressing member applied to the wound of the human body.
- 제9항에 있어서,The method of claim 9,상기 밴드부재의 일면에 부착되고, 상기 드레싱부재의 이외의 영역에 대응하는 부분이 편향적 탄성을 갖도록 직조되는 외피부재가 더 포함되는 의료용 밴드.The medical band is attached to one surface of the band member, the medical band further comprises a sheath member woven so that the portion corresponding to the region other than the dressing member has a biased elasticity.
- 제8항 또는 제9항에 있어서,The method according to claim 8 or 9,상기 드레싱부재는 항생제, 연고, 소염제, 진통제, 창상치유 성장인자, 호르몬, 스테로이드, 자가이식 세포 및 합성 조직재생 촉진제 중 적어도 어느 하나 이상을 포함하는 의료용 밴드.The dressing member is a medical band comprising at least one or more of antibiotics, ointments, anti-inflammatory agents, analgesics, wound healing growth factors, hormones, steroids, autologous cells and synthetic tissue regeneration accelerator.
- 제8항 또는 제9항에 있어서,The method according to claim 8 or 9,상기 드레싱부재는 습윤 드레싱 제재로 형성되는 의료용 밴드.The medical dressing member is formed of a wet dressing material.
- 제12항에 있어서,The method of claim 12,상기 드레싱부재는 하이드로콜로이드, 폴리우레탄 폼, 폴리우레탄 필름 및 하이드로겔 중 적어도 어느 하나의 재질로 형성된 레이어를 포함하는 의료용 밴드.The dressing member is a medical band comprising a layer formed of at least one material of a hydrocolloid, polyurethane foam, polyurethane film and hydrogel.
- 제13항에 있어서,The method of claim 13,상기 드레싱부재는 카르복시메틸 셀룰로오스(carboxymethyl cellulose, CMC) 파우더 또는 상기 CMC 파우더를 포함하는 혼합물 중 어느 하나로 형성된 하이드로콜로이드 레이어를 포함하는 의료용 밴드.The dressing member is a medical band comprising a hydrocolloid layer formed of any one of the carboxymethyl cellulose (CMC) powder or a mixture containing the CMC powder.
- 제14항에 있어서,The method of claim 14,상기 CMC 파우더 혼합물은 CMC 파우더와 젤라틴(Gelatin), 펙틴(Pectin), 알지네이트(alginate) 및 수지(gum) 중 적어도 어느 하나의 파우더의 혼합 및 고형화에 의하여 형성되는 의료용 밴드.The CMC powder mixture is a medical band formed by mixing and solidifying CMC powder and powder of at least one of gelatin, gelatin, pectin, alginate and resin.
- 제15항에 있어서,The method of claim 15,상기 고형화 시 상기 CMC 파우더 혼합물은 폴리이소부틸렌(polyisobutylene)에 의하여 접착되는 의료용 밴드.The CMC powder mixture is bonded to the medical band by polyisobutylene when the solidification.
- 제1항에 있어서,The method of claim 1,상기 자석 부재는 영구 자석 및 전자석 중 어느 하나의 타입으로 구비되는 의료용 밴드.The magnetic member is a medical band provided with any one type of permanent magnets and electromagnets.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201580046244.6A CN106604702B (en) | 2014-07-01 | 2015-07-01 | Medical belt |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2014-0082051 | 2014-07-01 | ||
KR1020140082051A KR101587627B1 (en) | 2014-07-01 | 2014-07-01 | Medical bandage |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016003203A1 true WO2016003203A1 (en) | 2016-01-07 |
Family
ID=55019647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2015/006785 WO2016003203A1 (en) | 2014-07-01 | 2015-07-01 | Medical band |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR101587627B1 (en) |
CN (1) | CN106604702B (en) |
WO (1) | WO2016003203A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101937052B1 (en) * | 2017-09-29 | 2019-01-09 | 인제대학교 산학협력단 | Medical biomaterials unit and Applicator for attaching the mdical biomaterials unit |
KR102281144B1 (en) | 2019-08-30 | 2021-07-22 | 인제대학교 산학협력단 | Medical biomaterial unit and Applicator for attaching the mdical biomaterial unit |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3069449U (en) * | 1999-12-06 | 2000-06-23 | 正道 秋山 | Magnetic therapy tools |
JP2006325716A (en) * | 2005-05-24 | 2006-12-07 | Aso Seiyaku Kk | Adhesive plaster with magnet |
KR20090076889A (en) * | 2006-06-23 | 2009-07-13 | 젠테크 인크 | Superthin wound dressing having folded release sheet |
KR20130002638U (en) * | 2011-10-24 | 2013-05-03 | (주)영케미칼 | Dressing band |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0790864B2 (en) * | 1989-07-31 | 1995-10-04 | 隆雄 束村 | Method and apparatus for manufacturing metal container having winding portion |
JP3069449B2 (en) * | 1992-09-18 | 2000-07-24 | 新電元工業株式会社 | Electrophotographic photoreceptor |
JP2001187153A (en) | 1999-12-28 | 2001-07-10 | Tokin Corp | Magnetotherapy sheet containing tourmaline and manufacture thereof |
CN201194878Y (en) * | 2008-05-26 | 2009-02-18 | 徐茂山 | Notch plaster used after operation |
CN203370019U (en) * | 2013-03-22 | 2014-01-01 | 张志伟 | Strong magnetic band aid |
CN203953717U (en) * | 2014-05-05 | 2014-11-26 | 兰州大学 | A kind of adjustable magnetic Skin stretching device |
-
2014
- 2014-07-01 KR KR1020140082051A patent/KR101587627B1/en active IP Right Grant
-
2015
- 2015-07-01 WO PCT/KR2015/006785 patent/WO2016003203A1/en active Application Filing
- 2015-07-01 CN CN201580046244.6A patent/CN106604702B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3069449U (en) * | 1999-12-06 | 2000-06-23 | 正道 秋山 | Magnetic therapy tools |
JP2006325716A (en) * | 2005-05-24 | 2006-12-07 | Aso Seiyaku Kk | Adhesive plaster with magnet |
KR20090076889A (en) * | 2006-06-23 | 2009-07-13 | 젠테크 인크 | Superthin wound dressing having folded release sheet |
KR20130002638U (en) * | 2011-10-24 | 2013-05-03 | (주)영케미칼 | Dressing band |
Also Published As
Publication number | Publication date |
---|---|
CN106604702A (en) | 2017-04-26 |
KR20160003989A (en) | 2016-01-12 |
CN106604702B (en) | 2020-10-13 |
KR101587627B1 (en) | 2016-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3896802A (en) | Flexible flocked dressing | |
SE0100284D0 (en) | Medical communication system | |
WO2016003203A1 (en) | Medical band | |
ES2153313B1 (en) | APPARATUS FOR THE GUIDED APPLICATION OF A RETRACTABLE CLAMP FOR THE PRECUTE CLOSURE OF ORIFICES, INCISIONS OR LACERATIONS IN VESSELS, DUCTS OR ANATOMICAL STRUCTURES, HUMAN RETRACTABLE AND PROCEDURE FOR APPLICATION. | |
WO2015135351A1 (en) | Liquid-absorption wound dressing helping to observe wound surface | |
SE9001033D0 (en) | IMPLANTABLE DEVICE FOR SUSPENSION OF A CHANNEL IN THE BODY OF A LIVE BEING | |
BR0208003A (en) | Bicarbonate based solutions for dialysis therapies | |
CN210408722U (en) | Orthopedic splint | |
YU11802A (en) | Preparation containing one or more antibiotics with delayed active substance release and use thereof | |
SU1468511A1 (en) | Arrangement for fixing | |
WO2014109437A1 (en) | Central venous catheter kit | |
WO2023177088A1 (en) | Pressing magnetic wristband | |
WO2016108585A1 (en) | Medical magnet band | |
CN215425511U (en) | Superficial infection wound dressing | |
CN217448674U (en) | Drainage tube anticreep is pasted | |
WO2017084153A1 (en) | First-aid bandage wrapped around a wound capable of regularly reminding the wounded of unwrapping same | |
CN205814546U (en) | A kind of knee joint wound dressing knee cap | |
KR20080107173A (en) | Splint having a function of quantum treatment | |
CN214104467U (en) | Infection source isolation and collection device | |
CN221357408U (en) | Detachable wound dressing convenient to observe | |
ZA961919B (en) | Use of magnetites to determine the perfusion of human tissue with the aid of mr diagnosis | |
CN204995652U (en) | Thorax operation postoperative is fixed bandage fast | |
WO2019172514A1 (en) | Insertion-type drainage tube using absorbent material | |
CN221577911U (en) | Quick hemostatic bandaging device | |
CN216985026U (en) | Novel first-aid tourniquet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15814774 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15814774 Country of ref document: EP Kind code of ref document: A1 |